Natural Support

Evidence-based nutritional and lifestyle approaches for post-acute COVID-19 sequelae, addressing oxidative stress, gut dysbiosis, persistent inflammation, and mitochondrial recovery

Long COVID — formally called post-acute sequelae of SARS-CoV-2 (PASC) — refers to symptoms that persist or emerge weeks to months after acute infection has resolved. The most common complaints are profound fatigue, brain fog, breathlessness, and post-exertional malaise: a worsening of symptoms after physical or mental effort that can set recovery back significantly [1]. A large 2-year follow-up of nearly 140,000 individuals showed that risk for most post-acute symptoms attenuated over time in people who were not hospitalised, though full resolution is not guaranteed [1]. Overlapping biological mechanisms — oxidative stress, gut dysbiosis, persistent low-grade inflammation, and vitamin D insufficiency — suggest that targeted nutritional and lifestyle support may meaningfully reduce symptom burden alongside medical care [2][3][5].

What Drives Long COVID Symptoms

Long COVID is not a single mechanism but a cluster of overlapping dysfunctions. Four drivers are well-supported by current research and directly inform natural interventions:

Oxidative stress and glutathione depletion. SARS-CoV-2 infection depletes glutathione — the body's principal intracellular antioxidant — and generates significant reactive oxygen species. This oxidative burden can persist long after viral clearance and may account for fatigue, breathlessness, and exercise intolerance. Some researchers also implicate microthrombi (tiny clots in capillaries) driven partly by elevated von Willebrand factor, a pro-clotting protein that oxidative stress helps sustain.

Gut microbiome disruption. COVID-19 consistently disturbs the gut microbiome, and in patients who develop Long COVID, dysbiosis persists for at least one year after discharge [2]. Beneficial bacteria that produce short-chain fatty acids — including Faecalibacterium prausnitzii and Bifidobacterium species — are significantly depleted. This affects intestinal barrier integrity, immune regulation, and the gut-brain axis, potentially contributing to cognitive symptoms and mood changes.

Persistent low-grade inflammation. Elevated inflammatory cytokines have been measured months post-infection in Long COVID patients, particularly in those with fatigue and cognitive symptoms. Omega-3 fatty acids influence the resolution of inflammation through specialized pro-resolving mediator (SPM) pathways and have been studied specifically in the post-COVID context [4].

Vitamin D insufficiency. COVID-19 patients who develop vitamin D deficiency are at elevated risk of adverse post-acute outcomes [5]. Vitamin D is involved in both innate and adaptive immune regulation and modulates the renin-angiotensin system — the same pathway SARS-CoV-2 exploits via the ACE2 receptor.

NAC for Oxidative Stress and Dyspnea

N-acetylcysteine (NAC) is one of the most biologically plausible interventions for Long COVID. It raises intracellular glutathione, reduces oxidative stress and inflammation, and has a property particularly relevant here: it breaks disulfide bonds in von Willebrand factor multimers, potentially helping dissolve microthrombi that contribute to circulatory and respiratory symptoms.

A pilot study in Long COVID patients found that NAC supplementation (600 mg twice daily for 12 weeks) significantly improved dyspnea scores and appeared to normalize elevated von Willebrand factor levels in the majority of treated patients [3]. Typical supplemental dosing in trials ranges from 600–1800 mg/day in divided doses, taken with food to reduce gastrointestinal upset. NAC is widely available as an over-the-counter supplement and has a well-established safety record at these doses.

See our NAC page for more on its mechanisms and applications.

Gut Restoration: Probiotics, Fermented Foods, and Prebiotic Fiber

Restoring the microbiome is one of the most tangible targets for Long COVID support. Multi-strain probiotics containing Bifidobacterium longum and Lactobacillus species are a practical starting point, particularly strains among those consistently depleted in Long COVID patients [2].

Dietary strategies matter equally. Fermented foods — kefir, kimchi, yogurt, sauerkraut, tempeh — deliver live cultures alongside fermentation metabolites. Prebiotic fiber from Jerusalem artichoke, chicory root, garlic, leeks, and oats feeds the beneficial bacteria that need to re-establish. Butyrate, a short-chain fatty acid produced by microbes fermenting fiber, provides fuel for colonocytes and helps restore gut barrier integrity. A diet rich in diverse plant fibers with daily fermented food intake is one of the most evidence-consistent approaches to rebuilding microbial diversity.

See our gut microbiome page and fermented foods overview for more.

Omega-3 Fatty Acids for Inflammation Resolution

A large retrospective study of 33,908 COVID-19 patients found omega-3 use was associated with lower rates of post-COVID cough and myalgia, though effects on brain fog and fatigue were not statistically significant in this analysis [4]. While omega-3 alone is unlikely to resolve Long COVID's cognitive burden, its anti-inflammatory and pro-resolving mechanisms remain relevant in the setting of sustained systemic inflammation.

EPA and DHA at 2–4 g/day total — from fish oil or algal oil — represent the best-studied forms. Taking omega-3 with the largest meal of the day reduces the aftertaste associated with some products and improves absorption. Phospholipid-bound omega-3 (krill oil) may offer superior uptake for some individuals.

Vitamin D Assessment and Correction

Given the demonstrated association between post-acute vitamin D deficiency and worse outcomes, testing serum 25-hydroxyvitamin D levels is a practical early step for anyone with Long COVID [5]. Most integrative clinicians target 50–80 ng/mL (125–200 nmol/L). Vitamin D3 at 2000–5000 IU daily alongside vitamin K2 (100–200 mcg MK-7) supports optimal utilization and prevents inappropriate calcium deposition. Testing is essential before high-dose supplementation to avoid over-correction.

Pacing and Nervous System Support

Post-exertional malaise — symptom worsening after exertion that exceeds a person's current capacity — is a hallmark of Long COVID that distinguishes it from simple deconditioning. Vigorous exercise and aggressive rehabilitation can worsen this condition, particularly in the first months. Pacing — deliberately staying below the symptomatic threshold — is consistently recommended by specialist clinics.

Many Long COVID patients also experience dysautonomia (autonomic dysfunction): heart palpitations, orthostatic intolerance, and difficulty regulating temperature. Vagal nerve support is practical here: slow diaphragmatic breathing (extending the exhale to 6–8 seconds), gentle yoga, and cold water splashed on the face activate the parasympathetic brake on the sympathetic nervous system. See our vagus nerve page for techniques with published evidence.

Additional considerations: magnesium glycinate (300–400 mg at night) supports sleep and muscle recovery; CoQ10 (200–400 mg/day) supports mitochondrial energy production; and adequate protein intake (1.2–1.6 g/kg body weight) preserves muscle during a period when activity may be limited.

Evidence Review

Long-Term Trajectory: Nature Medicine Cohort

Bowe et al. (2023) followed 138,818 individuals with confirmed SARS-CoV-2 infection alongside 5,985,227 non-infected controls from the US Department of Veterans Affairs database for two years, systematically comparing risks for 80 pre-specified post-acute sequelae [1]. By two years, risks in non-hospitalised individuals had largely attenuated toward baseline for most outcomes, though fatigue, respiratory, and cognitive symptoms remained modestly elevated. In hospitalised individuals, elevated risk persisted across multiple organ systems — cardiovascular, pulmonary, and neurological — throughout the two-year follow-up.

The study provides crucial epidemiological context: Long COVID trajectory is heavily dependent on acute illness severity. Non-hospitalised patients have better recovery prospects, while those with severe initial illness face more durable sequelae. Important limitations: the cohort was predominantly older male veterans, which may not represent younger, female, or otherwise healthier populations who represent a large proportion of Long COVID cases in the general community.

Gut Microbiome Dysbiosis at One Year

Zhang et al. (2023) enrolled 187 recovered COVID-19 patients alongside 30 healthy controls, performing 16S rRNA gene sequencing of stool samples at one year post-discharge [2]. Of the recovered patients, 84 (44.9%) reported persistent Long COVID symptoms. Symptomatic patients showed significantly reduced alpha-diversity (Shannon index) compared to both asymptomatic recovered patients and healthy controls.

Specifically, Long COVID patients showed depletion of Faecalibacterium prausnitzii, Roseburia intestinalis, and Bifidobacterium species — all short-chain fatty acid producers — alongside enrichment of potentially pathogenic taxa including Ruminococcus gnavus and Bacteroides vulgatus. Stool butyrate concentrations correlated inversely with symptom severity scores. Limitations include the relatively small sample, single-center Chinese hospital design, and that 16S rRNA methodology identifies taxa without strain-level resolution. These findings are nonetheless consistent with multiple independent microbiome studies in Long COVID patients, increasing confidence that gut dysbiosis is a real and persistent feature of the condition rather than an artifact.

NAC for Dyspnea and Vascular Markers

Bellone et al. (2025) reported on 26 gynecologic oncology patients who developed Long COVID/PASC and received NAC 600 mg twice daily for 12 weeks [3]. Dyspnea scores (modified Medical Research Council scale) improved significantly, with mean mMRC scores decreasing from 2.4 at baseline to 0.9 at 12 weeks. Von Willebrand factor antigen levels, elevated at baseline (mean 187% of normal), normalized toward reference range in 73% of treated patients.

The authors propose that NAC's ability to break disulfide bonds in vWF multimers may directly address one mechanism driving Long COVID respiratory and circulatory symptoms — a hypothesis consistent with emerging microclot literature. Key limitations: this was a small, non-randomized pilot study in a cancer patient population, which substantially limits generalizability to the general Long COVID population. Cancer and its treatment independently affect oxidative stress and coagulation markers. A randomized, placebo-controlled trial in a general Long COVID cohort is needed to confirm the vWF normalization finding.

Omega-3 and Post-Acute Psychiatric and Somatic Sequelae

Liu et al. (2023) conducted a retrospective cohort analysis of 33,908 COVID-19 patients from a large US electronic health records database, comparing those with documented omega-3 prescription use versus non-users over one year [4]. Omega-3 use was associated with statistically significant reductions in post-COVID cough (odds ratio 0.71, 95% CI 0.57–0.88) and myalgia (OR 0.75, 95% CI 0.58–0.97). However, no significant associations were found for fatigue, headache, or cognitive symptoms.

The study is notable for its large size, but inherits the limitations of retrospective pharmacy record analysis: omega-3 dosing was not standardized, prescription-based omega-3 (typically at very high doses for hypertriglyceridemia) may differ in effect from lower-dose OTC supplementation, and confounding by health-conscious behavior is difficult to fully exclude. The null finding for brain fog and fatigue indicates that omega-3 supplementation alone, at typical doses, is likely insufficient as a primary cognitive intervention in Long COVID — even as its anti-inflammatory properties may provide modest benefit for systemic symptoms.

Vitamin D Deficiency and Post-Acute Outcomes

Wu et al. (2024) examined post-acute outcomes in COVID-19 patients stratified by vitamin D status, drawing on data from a multicenter Taiwanese cohort [5]. COVID-19 patients with vitamin D deficiency (< 20 ng/mL) had a 1.41-fold higher risk of all-cause emergency department visits during the post-acute phase (HR 1.41, 95% CI 1.09–1.82), independent of age, sex, comorbidities, and vaccination status. Trends toward higher hospitalization were observed but did not reach statistical significance.

This association does not prove causality — vitamin D deficiency may be a marker of poor overall health or limited sun exposure rather than a direct modifiable driver of Long COVID severity. However, given the low cost, the good safety profile of correcting deficiency to normal range, and vitamin D's established roles in immune modulation and ACE2 expression regulation, supplementation to normalize levels represents a reasonable and practical low-risk intervention for Long COVID patients with confirmed insufficiency.

References

Postacute sequelae of COVID-19 at 2 yearsBowe B, Xie Y, Al-Aly Z. Nature Medicine, 2023. PubMed 37605079 →
Gut Microbiota Dysbiosis Correlates With Long COVID-19 at One-Year After DischargeZhang D, Zhou Y, Ma Y, Chen P, Tang J, Yang B. Journal of Korean Medical Science, 2023. PubMed 37069814 →
N-acetylcysteine (NAC) supplementation improves dyspnea and may normalize von Willebrand plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVIDBellone S, Siegel ER, Santin AD. Gynecologic Oncology Reports, 2025. PubMed 39944180 →
Omega-3 polyunsaturated fatty acids and the psychiatric post-acute sequelae of COVID-19: A one-year retrospective cohort analysis of 33,908 patientsLiu TH, Ho CH, Chen DT, Wu JY, Huang PY, Lai CC. Brain, Behavior, and Immunity, 2023. PubMed 37716377 →
Association between vitamin D deficiency and post-acute outcomes of SARS-CoV-2 infectionWu JY, Liu MY, Hsu WH, Tsai YW, Liu TH, Huang PY. European Journal of Nutrition, 2024. PubMed 38112761 →